Valeant Pharmaceuticals reported $1.92B in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amgen AMGN:US $ 6238M 608M
Ani Pharmaceuticals ANIP:US $ 64.48M 3.55M
Aurora Cannabis Inc ACB:CN 50.43M 10.15M
Biogen BIIB:US $ 2531.8M 202M
Bristol Myers Squibb BMY:US $ 11648M 337M
Canopy Growth Corp WEED:CN C$ 111.77M 29.2M
Catalent CTLT:US $ 1273M 56M
Corcept Therapeutics CORT:US $ 93.69M 5.13M
Danaher DHR:US $ 7688M 460M
Eli Lilly And LLY:US $ 7810M 189.9M
Endo International Ordinary Shares ENDP:US $ 652.26M 137.17M
Gilead Sciences GILD:US $ 6590M 654M
Horizon Pharma HZNP:US $ 885.24M 129.22M
JAZZ PHA JAZZ:US $ 813.72M 83.01M
Lannett LCI:US $ 78.36M 8.15M
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Pacira Pharmaceuticals PCRX:US $ 157.99M 1.2M
Perrigo Ordinary Shares PRGO:US $ 1074.5M 30.4M
Phibro Animal Health PAHC:US $ 239.62M 6.91M
Prestige Brands PBH:US $ 266.94M 7.53M
Revance Therapeutics RVNC:US $ 25.26M 0.69M
Supernus Pharmaceuticals SUPN:US $ 152.51M 6.54M
Valeant Pharmaceuticals VRX:CN $ 1918M 278M
Vertex Pharmaceuticals VRTX:US $ 2097.5M 24.94M
Zoetis ZTS:US $ 1986M 19M